Three years of falling overdose deaths spark cautious optimism amid lingering concerns

Over the past three years, the United States has seen a steady decline in overdose deaths, a trend that has generated cautious optimism among public‑health observers. While the numbers are encouraging, experts caution that the improvement may be fragile and that underlying risks remain.

Analysts note that the downward trajectory could be reversed if preventive measures lapse or if new substances emerge, so continued vigilance is essential.

The article also reports that the Trump administration is searching for a new FDA commissioner after Marty Makary stepped down, seeking a leader who can rebuild staff trust, address food‑policy issues, and advance drug‑approval reforms.

In addition, STAT highlights an interview with Helen Branswell about the challenges of covering the current hantavirus outbreak, underscoring the CDC’s ongoing response efforts.

Readers are invited to follow these developments through STAT’s Morning Rounds newsletter, which provides daily health and medicine updates.